Tenofovir Alafenamide Fumarate tablets

DRUG2 trials

Sponsors

Southeast University, China, Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

Conditions

Chronic Hepatitis BHepatitis B VirusMother to Child Transmission

Phase 3

Clinical Trial of TQA3605 Tablet in Combination With Nucleos(t)Ide Analogues(NAs) Versus NAs Alone for the Treatment of Patients With Chronic Hepatitis B Virus Infection Who Have Undergone Treatment and Exhibit Low Viral Load or Poor Response

Not yet recruitingNCT07797231

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.Chronic Hepatitis B

Start: 2026-09-01End: 2029-10-01Target: 930Updated: 2026-09-03

Unknown Phase

Study of Tenofovir Alafenamide Fumarate Tablets (TAF) in Blocking Mother-to-child Transmission of Hepatitis B Virus

Southeast University, ChinaHepatitis B Virus, Mother to Child Transmission

Start: 2019-08-31End: 2021-08-31Target: 330Updated: 2019-08-22

Related Papers

Tenofovir alafenamide in blocking mother-to-child transmission of hepatitis B virus: a multi-center, prospective study

The Journal of Maternal-Fetal & Neonatal Medicine2022-10-177 citations